Listed

cbdMD, Inc.

YCBDNYSECIK 1644903Consumer staplesFiscal year ends Sep 30

Latest reported revenue, Q3 FY2026$5.6mRevenue, Q3 FY2026, three months to 2026-06-30$5.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0001437749-26-027665.Report this figureThree months to Jun 30, 2026, from the 10-Q filed Aug 13, 2026.

Latest quarter: Q3 FY2026

Three months to Jun 30, 2026, against the same quarter a year earlier.

  • Revenue$5.6mRevenue, Q3 FY2026, three months to 2026-06-30$5.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0001437749-26-027665.Report this figure+20.6% on a year earlier
  • Gross margin54.7%Gross margin, Q3 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $3.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-13, accession 0001437749-26-027665.Revenue: $5.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0001437749-26-027665.Report this figure−6.8 pts on a year earlier
  • Operating margin−20.4%Operating margin, Q3 FY2026, three months to 2026-06-30. operating income / revenueOperating income: −$1.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001437749-26-027665.Revenue: $5.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0001437749-26-027665.Report this figure−0.7 pts on a year earlier
  • Net margin−20.3%Net margin, Q3 FY2026, three months to 2026-06-30. net income / revenueNet income: −$1.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001437749-26-027665.Revenue: $5.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0001437749-26-027665.Report this figure−0.9 pts on a year earlier
  • Diluted EPSnot reported (Diluted EPS not reported)No year-earlier figure to compare
  • Free cash flow−$460.2kFree cash flow, Q3 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: −$442.2k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001437749-26-027665. Derived: 9-month figure less the 6-month figure.Capital expenditure: $18.1k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001437749-26-027665. Derived: 9-month figure less the 6-month figure.Report this figure+34.8% on a year earlier

Last eight quarters

Full statements
Revenue$5.6mGross margin 54.7%
Free cash flow−$460.2k, Q3 FY2026
cbdMD, Inc., key figures for the last eight quarters
Line itemUnitQ4 FY20242024-09-30Q1 FY20252024-12-31Q2 FY20252025-03-31Q3 FY20252025-06-30Q4 FY20252025-09-30Q1 FY20262025-12-31Q2 FY20262026-03-31Q3 FY20262026-06-30Shape over the periods
Revenue$k4,556Revenue, Q4 FY2024, three months to 2024-09-30$4.6m. XBRL concept us-gaap:Revenues. 10-K filed 2025-12-19, accession 0001437749-25-038435. Derived: 12-month figure less the 9-month figure.Report this figure5,113Revenue, Q1 FY2025, three months to 2024-12-31$5.1m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-02-17, accession 0001437749-26-004343.Report this figure4,749Revenue, Q2 FY2025, three months to 2025-03-31$4.7m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-14, accession 0001437749-26-017042.Report this figure4,607Revenue, Q3 FY2025, three months to 2025-06-30$4.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0001437749-26-027665.Report this figure4,721Revenue, Q4 FY2025, three months to 2025-09-30$4.7m. XBRL concept us-gaap:Revenues. 10-K filed 2025-12-19, accession 0001437749-25-038435. Derived: 12-month figure less the 9-month figure.Report this figure5,017Revenue, Q1 FY2026, three months to 2025-12-31$5.0m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-02-17, accession 0001437749-26-004343.Report this figure5,640Revenue, Q2 FY2026, three months to 2026-03-31$5.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-14, accession 0001437749-26-017042.Report this figure5,554Revenue, Q3 FY2026, three months to 2026-06-30$5.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0001437749-26-027665.Report this figure
Gross margin%53.9%Gross margin, Q4 FY2024, three months to 2024-09-30. gross profit / revenueGross profit: $2.5m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-12-19, accession 0001437749-25-038435. Derived: 12-month figure less the 9-month figure.Revenue: $4.6m. XBRL concept us-gaap:Revenues. 10-K filed 2025-12-19, accession 0001437749-25-038435. Derived: 12-month figure less the 9-month figure.Report this figure66.5%Gross margin, Q1 FY2025, three months to 2024-12-31. gross profit / revenueGross profit: $3.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-02-17, accession 0001437749-26-004343.Revenue: $5.1m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-02-17, accession 0001437749-26-004343.Report this figure62.3%Gross margin, Q2 FY2025, three months to 2025-03-31. gross profit / revenueGross profit: $3.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-14, accession 0001437749-26-017042.Revenue: $4.7m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-14, accession 0001437749-26-017042.Report this figure61.5%Gross margin, Q3 FY2025, three months to 2025-06-30. gross profit / revenueGross profit: $2.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-13, accession 0001437749-26-027665.Revenue: $4.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0001437749-26-027665.Report this figure58.8%Gross margin, Q4 FY2025, three months to 2025-09-30. gross profit / revenueGross profit: $2.8m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-12-19, accession 0001437749-25-038435. Derived: 12-month figure less the 9-month figure.Revenue: $4.7m. XBRL concept us-gaap:Revenues. 10-K filed 2025-12-19, accession 0001437749-25-038435. Derived: 12-month figure less the 9-month figure.Report this figure59.8%Gross margin, Q1 FY2026, three months to 2025-12-31. gross profit / revenueGross profit: $3.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-02-17, accession 0001437749-26-004343.Revenue: $5.0m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-02-17, accession 0001437749-26-004343.Report this figure57.7%Gross margin, Q2 FY2026, three months to 2026-03-31. gross profit / revenueGross profit: $3.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-14, accession 0001437749-26-017042.Revenue: $5.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-14, accession 0001437749-26-017042.Report this figure54.7%Gross margin, Q3 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $3.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-13, accession 0001437749-26-027665.Revenue: $5.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0001437749-26-027665.Report this figure
Operating margin%(6.9%)Operating margin, Q4 FY2024, three months to 2024-09-30. operating income / revenueOperating income: −$316.6k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-12-19, accession 0001437749-25-038435. Derived: 12-month figure less the 9-month figure.Revenue: $4.6m. XBRL concept us-gaap:Revenues. 10-K filed 2025-12-19, accession 0001437749-25-038435. Derived: 12-month figure less the 9-month figure.Report this figure(1.7%)Operating margin, Q1 FY2025, three months to 2024-12-31. operating income / revenueOperating income: −$86.3k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-02-17, accession 0001437749-26-004343.Revenue: $5.1m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-02-17, accession 0001437749-26-004343.Report this figure(10.2%)Operating margin, Q2 FY2025, three months to 2025-03-31. operating income / revenueOperating income: −$485.8k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001437749-26-017042.Revenue: $4.7m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-14, accession 0001437749-26-017042.Report this figure(19.6%)Operating margin, Q3 FY2025, three months to 2025-06-30. operating income / revenueOperating income: −$904.7k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001437749-26-027665.Revenue: $4.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0001437749-26-027665.Report this figure(14.5%)Operating margin, Q4 FY2025, three months to 2025-09-30. operating income / revenueOperating income: −$685.8k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-12-19, accession 0001437749-25-038435. Derived: 12-month figure less the 9-month figure.Revenue: $4.7m. XBRL concept us-gaap:Revenues. 10-K filed 2025-12-19, accession 0001437749-25-038435. Derived: 12-month figure less the 9-month figure.Report this figure(5.7%)Operating margin, Q1 FY2026, three months to 2025-12-31. operating income / revenueOperating income: −$286.3k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-02-17, accession 0001437749-26-004343.Revenue: $5.0m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-02-17, accession 0001437749-26-004343.Report this figure(14.2%)Operating margin, Q2 FY2026, three months to 2026-03-31. operating income / revenueOperating income: −$800.8k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001437749-26-017042.Revenue: $5.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-14, accession 0001437749-26-017042.Report this figure(20.4%)Operating margin, Q3 FY2026, three months to 2026-06-30. operating income / revenueOperating income: −$1.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001437749-26-027665.Revenue: $5.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0001437749-26-027665.Report this figure
Net margin%(3.4%)Net margin, Q4 FY2024, three months to 2024-09-30. net income / revenueNet income: −$152.8k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-12-18, accession 0001437749-24-037840.Revenue: $4.6m. XBRL concept us-gaap:Revenues. 10-K filed 2025-12-19, accession 0001437749-25-038435. Derived: 12-month figure less the 9-month figure.Report this figure0.3%Net margin, Q1 FY2025, three months to 2024-12-31. net income / revenueNet income: $15.1k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-02-17, accession 0001437749-26-004343.Revenue: $5.1m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-02-17, accession 0001437749-26-004343.Report this figure(10.1%)Net margin, Q2 FY2025, three months to 2025-03-31. net income / revenueNet income: −$480.8k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-14, accession 0001437749-26-017042.Revenue: $4.7m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-14, accession 0001437749-26-017042.Report this figure(19.4%)Net margin, Q3 FY2025, three months to 2025-06-30. net income / revenueNet income: −$895.3k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001437749-26-027665.Revenue: $4.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0001437749-26-027665.Report this figure(14.4%)Net margin, Q4 FY2025, three months to 2025-09-30. net income / revenueNet income: −$680.0k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-12-19, accession 0001437749-25-038435. Derived: 12-month figure less the 9-month figure.Revenue: $4.7m. XBRL concept us-gaap:Revenues. 10-K filed 2025-12-19, accession 0001437749-25-038435. Derived: 12-month figure less the 9-month figure.Report this figure(5.6%)Net margin, Q1 FY2026, three months to 2025-12-31. net income / revenueNet income: −$283.1k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-02-17, accession 0001437749-26-004343.Revenue: $5.0m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-02-17, accession 0001437749-26-004343.Report this figure(14.1%)Net margin, Q2 FY2026, three months to 2026-03-31. net income / revenueNet income: −$798.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-14, accession 0001437749-26-017042.Revenue: $5.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-14, accession 0001437749-26-017042.Report this figure(20.3%)Net margin, Q3 FY2026, three months to 2026-06-30. net income / revenueNet income: −$1.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001437749-26-027665.Revenue: $5.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0001437749-26-027665.Report this figure
Diluted EPS$ per sharenot reported (Diluted EPS not reported)not reported (Diluted EPS not reported)not reported (Diluted EPS not reported)not reported (Diluted EPS not reported)not reported (Diluted EPS not reported)not reported (Diluted EPS not reported)not reported (Diluted EPS not reported)not reported (Diluted EPS not reported)
Free cash flow$k157Free cash flow, Q4 FY2024, three months to 2024-09-30. operating cash flow − capital expenditureOperating cash flow: $167.4k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-12-19, accession 0001437749-25-038435. Derived: 12-month figure less the 9-month figure.Capital expenditure: $10.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-12-19, accession 0001437749-25-038435. Derived: 12-month figure less the 9-month figure.Report this figure(482)Free cash flow, Q1 FY2025, three months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: −$317.9k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-02-17, accession 0001437749-26-004343.Capital expenditure: $164.4k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-02-17, accession 0001437749-26-004343.Report this figure(205)Free cash flow, Q2 FY2025, three months to 2025-03-31. operating cash flow − capital expenditureOperating cash flow: −$189.5k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001437749-26-017042. Derived: 6-month figure less the 3-month figure.Capital expenditure: $15.5k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-14, accession 0001437749-26-017042. Derived: 6-month figure less the 3-month figure.Report this figure(706)Free cash flow, Q3 FY2025, three months to 2025-06-30. operating cash flow − capital expenditureOperating cash flow: −$704.2k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001437749-26-027665. Derived: 9-month figure less the 6-month figure.Capital expenditure: $1.5k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001437749-26-027665. Derived: 9-month figure less the 6-month figure.Report this figure(244)Free cash flow, Q4 FY2025, three months to 2025-09-30. operating cash flow − capital expenditureOperating cash flow: −$240.7k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-12-19, accession 0001437749-25-038435. Derived: 12-month figure less the 9-month figure.Capital expenditure: $2.8k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-12-19, accession 0001437749-25-038435. Derived: 12-month figure less the 9-month figure.Report this figure(977)Free cash flow, Q1 FY2026, three months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: −$812.5k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-02-17, accession 0001437749-26-004343.Capital expenditure: $164.8k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-02-17, accession 0001437749-26-004343.Report this figure(728)Free cash flow, Q2 FY2026, three months to 2026-03-31. operating cash flow − capital expenditureOperating cash flow: −$722.5k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001437749-26-017042. Derived: 6-month figure less the 3-month figure.Capital expenditure: $5.7k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-14, accession 0001437749-26-017042. Derived: 6-month figure less the 3-month figure.Report this figure(460)Free cash flow, Q3 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: −$442.2k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001437749-26-027665. Derived: 9-month figure less the 6-month figure.Capital expenditure: $18.1k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001437749-26-027665. Derived: 9-month figure less the 6-month figure.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$19.2mGross margin 62.4%
Diluted EPS−$1.09, FY2025
Free cash flow−$1.6m, FY2025
cbdMD, Inc., key figures for the last five fiscal years
Line itemUnitFY20212021-09-30FY20222022-09-30FY20232023-09-30FY20242024-09-30FY20252025-09-30Shape over the periods
Revenue$m44.5Revenue, FY2021, twelve months to 2021-09-30$44.5m. XBRL concept us-gaap:Revenues. 10-K filed 2022-12-15, accession 0001437749-22-029136.Report this figure35.4Revenue, FY2022, twelve months to 2022-09-30$35.4m. XBRL concept us-gaap:Revenues. 10-K filed 2023-12-22, accession 0001437749-23-035228.Report this figure24.2Revenue, FY2023, twelve months to 2023-09-30$24.2m. XBRL concept us-gaap:Revenues. 10-K filed 2024-12-18, accession 0001437749-24-037840.Report this figure19.5Revenue, FY2024, twelve months to 2024-09-30$19.5m. XBRL concept us-gaap:Revenues. 10-K filed 2025-12-19, accession 0001437749-25-038435.Report this figure19.2Revenue, FY2025, twelve months to 2025-09-30$19.2m. XBRL concept us-gaap:Revenues. 10-K filed 2025-12-19, accession 0001437749-25-038435.Report this figure
Gross margin%67.4%Gross margin, FY2021, twelve months to 2021-09-30. gross profit / revenueGross profit: $30.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2022-12-15, accession 0001437749-22-029136.Revenue: $44.5m. XBRL concept us-gaap:Revenues. 10-K filed 2022-12-15, accession 0001437749-22-029136.Report this figure63.1%Gross margin, FY2022, twelve months to 2022-09-30. gross profit / revenueGross profit: $22.3m. XBRL concept us-gaap:GrossProfit. 10-K filed 2023-12-22, accession 0001437749-23-035228.Revenue: $35.4m. XBRL concept us-gaap:Revenues. 10-K filed 2023-12-22, accession 0001437749-23-035228.Report this figure62.0%Gross margin, FY2023, twelve months to 2023-09-30. gross profit / revenueGross profit: $15.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2024-12-18, accession 0001437749-24-037840.Revenue: $24.2m. XBRL concept us-gaap:Revenues. 10-K filed 2024-12-18, accession 0001437749-24-037840.Report this figure61.6%Gross margin, FY2024, twelve months to 2024-09-30. gross profit / revenueGross profit: $12.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-12-19, accession 0001437749-25-038435.Revenue: $19.5m. XBRL concept us-gaap:Revenues. 10-K filed 2025-12-19, accession 0001437749-25-038435.Report this figure62.4%Gross margin, FY2025, twelve months to 2025-09-30. gross profit / revenueGross profit: $12.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-12-19, accession 0001437749-25-038435.Revenue: $19.2m. XBRL concept us-gaap:Revenues. 10-K filed 2025-12-19, accession 0001437749-25-038435.Report this figure
Operating margin%(44.1%)Operating margin, FY2021, twelve months to 2021-09-30. operating income / revenueOperating income: −$19.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2022-12-15, accession 0001437749-22-029136.Revenue: $44.5m. XBRL concept us-gaap:Revenues. 10-K filed 2022-12-15, accession 0001437749-22-029136.Report this figure(221.1%)Operating margin, FY2022, twelve months to 2022-09-30. operating income / revenueOperating income: −$78.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2023-12-22, accession 0001437749-23-035228.Revenue: $35.4m. XBRL concept us-gaap:Revenues. 10-K filed 2023-12-22, accession 0001437749-23-035228.Report this figure(93.1%)Operating margin, FY2023, twelve months to 2023-09-30. operating income / revenueOperating income: −$22.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-12-18, accession 0001437749-24-037840.Revenue: $24.2m. XBRL concept us-gaap:Revenues. 10-K filed 2024-12-18, accession 0001437749-24-037840.Report this figure(17.0%)Operating margin, FY2024, twelve months to 2024-09-30. operating income / revenueOperating income: −$3.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-12-19, accession 0001437749-25-038435.Revenue: $19.5m. XBRL concept us-gaap:Revenues. 10-K filed 2025-12-19, accession 0001437749-25-038435.Report this figure(11.3%)Operating margin, FY2025, twelve months to 2025-09-30. operating income / revenueOperating income: −$2.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-12-19, accession 0001437749-25-038435.Revenue: $19.2m. XBRL concept us-gaap:Revenues. 10-K filed 2025-12-19, accession 0001437749-25-038435.Report this figure
Net margin%(52.6%)Net margin, FY2021, twelve months to 2021-09-30. net income / revenueNet income: −$23.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2022-12-15, accession 0001437749-22-029136.Revenue: $44.5m. XBRL concept us-gaap:Revenues. 10-K filed 2022-12-15, accession 0001437749-22-029136.Report this figure(198.0%)Net margin, FY2022, twelve months to 2022-09-30. net income / revenueNet income: −$70.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2023-12-22, accession 0001437749-23-035228.Revenue: $35.4m. XBRL concept us-gaap:Revenues. 10-K filed 2023-12-22, accession 0001437749-23-035228.Report this figure(95.0%)Net margin, FY2023, twelve months to 2023-09-30. net income / revenueNet income: −$22.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-12-18, accession 0001437749-24-037840.Revenue: $24.2m. XBRL concept us-gaap:Revenues. 10-K filed 2024-12-18, accession 0001437749-24-037840.Report this figure(19.0%)Net margin, FY2024, twelve months to 2024-09-30. net income / revenueNet income: −$3.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-12-19, accession 0001437749-25-038435.Revenue: $19.5m. XBRL concept us-gaap:Revenues. 10-K filed 2025-12-19, accession 0001437749-25-038435.Report this figure(10.6%)Net margin, FY2025, twelve months to 2025-09-30. net income / revenueNet income: −$2.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-12-19, accession 0001437749-25-038435.Revenue: $19.2m. XBRL concept us-gaap:Revenues. 10-K filed 2025-12-19, accession 0001437749-25-038435.Report this figure
Diluted EPS$ per share(0.47)Diluted EPS, FY2021, twelve months to 2021-09-30−$0.47 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2022-12-15, accession 0001437749-22-029136.Report this figure(55.80)Diluted EPS, FY2022, twelve months to 2022-09-30−$55.80 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2023-12-22, accession 0001437749-23-035228.Report this figure(13.32)Diluted EPS, FY2023, twelve months to 2023-09-30−$13.32 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-12-18, accession 0001437749-24-037840.Report this figure(14.29)Diluted EPS, FY2024, twelve months to 2024-09-30−$14.29 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-12-19, accession 0001437749-25-038435.Report this figure(1.09)Diluted EPS, FY2025, twelve months to 2025-09-30−$1.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-12-19, accession 0001437749-25-038435.Report this figure
Free cash flow$m(14.4)Free cash flow, FY2021, twelve months to 2021-09-30. operating cash flow − capital expenditureOperating cash flow: −$14.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2022-12-15, accession 0001437749-22-029136.Capital expenditure: $342.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2022-12-15, accession 0001437749-22-029136.Report this figure(15.7)Free cash flow, FY2022, twelve months to 2022-09-30. operating cash flow − capital expenditureOperating cash flow: −$15.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2023-12-22, accession 0001437749-23-035228.Capital expenditure: $688.7k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2023-12-22, accession 0001437749-23-035228.Report this figure(4.6)Free cash flow, FY2023, twelve months to 2023-09-30. operating cash flow − capital expenditureOperating cash flow: −$4.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2024-12-18, accession 0001437749-24-037840.Capital expenditure: $297.5k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-12-18, accession 0001437749-24-037840.Report this figure(0.5)Free cash flow, FY2024, twelve months to 2024-09-30. operating cash flow − capital expenditureOperating cash flow: −$352.8k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-12-19, accession 0001437749-25-038435.Capital expenditure: $190.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-12-19, accession 0001437749-25-038435.Report this figure(1.6)Free cash flow, FY2025, twelve months to 2025-09-30. operating cash flow − capital expenditureOperating cash flow: −$1.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-12-19, accession 0001437749-25-038435.Capital expenditure: $184.2k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-12-19, accession 0001437749-25-038435.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding cbdMD, Inc.
FundQuarter endedReported valueSharesPut or callChange on the quarter before
Worth Venture Partners, LLC2026-06-30$124.4k184,796Unchanged
CSS LLC/IL2026-06-30$92.6k137,621Unchanged
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$80.5k119,645Added+68,592
CHAPIN DAVIS, INC.2026-06-30$54.7k81,250Unchanged
Alesco Advisors, LLC, An ESL Co2026-06-30$46.1k68,513Unchanged
Chicago Partners Investment Group LLC2026-06-30$45.0k78,098Added+64,598
XTX Topco Ltd2026-06-30$42.2k62,743Reduced−29,306
JANE STREET GROUP, LLC2026-06-30$36.6k54,401Reduced−21,937
VANGUARD FIDUCIARY TRUST CO2026-06-30$31.7k47,157Unchanged
UBS Group AG2026-06-30$14.5k21,576Reduced−143,067

Recent filings

All 535 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

cbdMD, Inc., recent filings
FiledFormWhat it isAccession number
2026-09-0207:30 ET8-K1.01 Entry into a material agreement; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001437749-26-029455
2026-08-1316:06 ET10-QQuarterly reportPeriod 2026-06-300001437749-26-027665
2026-05-2017:16 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001437749-26-017970
2026-05-1416:06 ET10-QQuarterly reportPeriod 2026-03-310001437749-26-017042
2026-04-1516:15 ET8-K8.01 Other events0001437749-26-012392
2026-04-0116:05 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001437749-26-010878
2026-02-2019:53 ETS-1/ARegistration statement, amended0001437749-26-004777
2026-02-1716:06 ET10-QQuarterly reportPeriod 2025-12-310001437749-26-004343
2026-02-1217:36 ETDEF 14AProxy statementPeriod 2026-03-300001437749-26-003831
2026-01-2209:14 ETS-1Registration statement0001437749-26-001692

Latest annual report

Form 10-K for the fiscal year ended Sep 30, 2025Filed Dec 19, 2025. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Q4 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by [object Promise].Forecast this quarter

About the filer

CIK
1644903
Tickers
YCBD
Exchange
NYSE
SIC code
2844 Perfumes, Cosmetics & Other Toilet Preparations
Sector
Consumer staples
Fiscal year ends
Sep 30
Incorporated in
NC
Filer category
Non-accelerated filer<br>Smaller reporting company
Former names
Level Brands, Inc. (to 2019-05-01); LEVEL BEAUTY GROUP, INC. (to 2016-09-27)

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:45 ET. Listed shows no prices and gives no investment advice.